Search results for: 'screen push'
- Did you mean
- screen pfph
- screen pfnh
- Related search terms
- Push-to-Talk over Cellular (PoC) Market in Southeast Asia, Forecast to 2028
- push ad flexible sensors
- push and paper chemicals markets
- push ad part chemicals markets
- push and paper chemicals market
-
07 Feb 2022  |  North America  |  Market Research
Growth Opportunities for Global Computer-aided Diagnosis (CAD) in Breast Cancer Screening
Artificial Intelligence and Deep Learning Support Better Clinical Outcomes and Fuel Growth Pipeline
This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due ...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Jun 2007  |  North America  |  Market Research
U.S. High Content Screening Markets
This research service analyzes the market for high content screening technologies within the United States. The market was divided into the high content screening instrumentation and high content screening reagents and assays segments. Each segment covers market trends, technology trends, competitive structure, market share analysis, revenue foreca...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Aug 2001  |  North America  |  Market Research
High Throughput Screening (HTS) in the U.S. Market
This report provides a strategic analysis and forecast of the HTS market. The major segments included in the scope of this report are consumables, contract screeners, and biotechnology& pharmaceuticals. Each segment covers technology, products, deals, patents, industry trends, and a revenue forecast and analysis. General market challenges, driver...
$2,450.00
Special Price $1,837.50 save 25 %
-
17 Jul 2017  |  North America  |  Market Research
US Oncology Diagnostics Market, Forecast to 2021
Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection
Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consolida...
$4,950.00
Special Price $3,712.50 save 25 %
-
05 Oct 2018  |  North America  |  Market Research
Growth Opportunities in the Global Liquid Biopsy Market, 2018
Companies are Vying for a Higher Market Position in the Early Cancer Screening Market
Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...
$4,950.00
Special Price $3,712.50 save 25 %
-
28 Jan 2020  |  North America  |  Market Research
Global Healthcare Cloud Computing Market, Forecast to 2023
Competitive Dynamics are Pushing Services to the Forefront
Cloud computing in healthcare is gaining momentum as a variety of factors create a significant need for the value propositions that a successful cloud implementation promises to offer. Global healthcare cloud market revenue is expected to surge at a compound annual growth rate of 25.1% from 2018 to 2023. Cloud computing involves the use of exter...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Nov 2016  |  North America  |  Market Research
The US Molecular Diagnostics Market, Forecast to 2021
Polymerase Chain Reaction (PCR) Holds Close to 53% Share but Strong Clinical Research will Push NGS to Revolutionize this Space in the Next 5 to 10 Ye
The US molecular diagnostics market is growing at 12.5% CAGR and is set to reach close to $6.5 billion by 2021. PCR, next-generation sequencing (NGS), microarray, and fluorescent in situ-hybridization (FISH) are the dominant technologies in this space with PCR holding more than 75% of the market. Roche, Cepheid, Qiagen, Abbott, and Thermo Fisher do...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Jul 2018  |  North America  |  Market Research
Global X-ray Mammography Imaging Systems Market, Forecast to 2022
Evaluating Growth Patterns and Opportunities Across X-ray Mammography Sets
Over the last 20 years, hospitals and imaging centers in developed economies have adopted X-ray mammography equipment to screen and diagnose breast cancer. This has led to significant reduction in mortality and prompted emerging countries to invest in population-based, organized screening. Significant investments in mammography technology have pave...
$4,950.00
Special Price $3,712.50 save 25 %
-
22 Dec 2019  |  North America  |  Technology Research
Imaging Innovations for Breast Cancer Diagnosis
Advances in Digital Technologies Enabling Early and Accurate Disease Diagnosis in FemTech Industry
The leading cause of cancer deaths in women globally is breast cancer. Regular breast cancer screening is imperative for early detection and timely intervention. Screening mammography is the method most commonly used worldwide for the detection of breast cancer. However, the traditional methods of screening are plagued by several challenges. Over t...
$4,950.00
Special Price $3,712.50 save 25 %
-
02 May 2018  |  North America  |  Technology Research
Breakthrough Innovations in PoC Diagnostics for Smart Healthcare
Rapid, Accessible, and Affordable Diagnostics Augmenting Healthcare
Today, the healthcare industry is focused toward patient centric care and preventative healthcare. Preventative healthcare involves regular screening and diagnosis for diseases before the condition becomes fatal. Early diagnosis improves the clinical outcome of the patients, reduces emergency visits, and subsequently healthcare costs. Usually, ear...
$4,950.00
Special Price $3,712.50 save 25 %